TNF-alpha variants proteins for the treatment of TNF-alpha related disorders
US7244823B2 · kind B2 · utility
29Cited by
24References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2002 |
| Grant date | Jul 17, 2007 |
| Priority date | — |
| Expiry date | Mar 31, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/525
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel proteins with TNF-alpha antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNF-alpha related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.